- YMAB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Y-mAbs Therapeutics (YMAB) 8-K27 Apr 21Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines AgencyFinancial data
Company Profile